Portland, OR, March 27, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global leukemia therapeutics market was estimated at $7.81 billion in 2021 and is expected to hit 14.16 billion by 2031, registering a CAGR of 6.1% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Request Sample PDF - https://www.alliedmarketresearch.com/request-sample/1447
Report coverage & details:
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $7.81 billion |
| Market Size in 2031 | $14.16 billion |
| CAGR | 6.1% |
| No. of Pages in Report | 392 |
| Segments Covered | Type, Drug Class, Distribution Channel, and Region. |
| Drivers | Rise in the incidence of leukemia |
| Surge in product approval | |
| Restraints | Side-effects and adverse reactions associated with leukemia therapeutics |
| High cost of leukemia treatment | |
| Opportunities | High growth potential in developing economies |
Impact of Covid-19 on the Leukemia Therapeutics Market-
- The global leukemia therapeutics market was negatively impacted due to the disruptions in cancer patient screening.
- The increased travel restrictions made it difficult for patients to seek necessary medical attention to diagnose and treat leukemia. However, the market has now recovered slowly and steadily.
Procure Complete Report (300 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/leukemia-therapeutics-market
The global leukemia therapeutics market is analyzed across type, drug class, distribution channel, and region. The report takes in an exhaustive analysis of the segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
By type, the chronic lymphocytic leukemia segment held the highest share in 2021, garnering nearly two-fifths of the global leukemia therapeutics market revenue. The same segment would also showcase the fastest CAGR of 6.5% throughout the forecast period. The acute lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, and others segments are also discussed throughout the study.
By drug class, the targeted therapy and immunotherapy segment contributed to nearly two-thirds of the global leukemia therapeutics market share in 2021, and is projected to rule the roost by 2031. The same segment would also display the fastest CAGR of 6.3% throughout the forecast period. The chemotherapy segment is also discussed in the report.
By distribution channel, the hospital pharmacies segment accounted for the highest share in 2021, generating nearly three-fifths of the global leukemia therapeutics market revenue. The online providers segment, on the other hand, would portray CAGR of 7.1% during the forecast period. The drug store & retail pharmacies segments are also analyzed through the study.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/1447
By region, North America held the major share in 2021, garnering more than two-fifths of the global leukemia therapeutics market revenue. Asia-Pacific, simultaneously, would showcase the fastest CAGR of 6.8% from 2022 to 2031. The other regions studied through the report include Europe and LAMEA.
The key market players analyzed in the global leukemia therapeutics market report include Amgen Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc., Teva Pharmaceutical Industries Limited, Lupin, Novartis AG, Pfizer Inc., Sanofi, Takeda Pharmaceutical Company Limited, and AbbVie Inc. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance and developments by the top players.
Trending Reports in Healthcare Industry:
Proton Therapy Market - Opportunity Analysis and Industry Forecast, 2022–2031
Non Small-Cell Lung Cancer Market- Opportunity Analysis and Industry Forecast, 2022–2031
Allergy Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2022–2031
Gas Chromatography Market- Global Opportunity Analysis and Industry Forecast, 2022–2031
Electrophoresis Market - Global Opportunity Analysis and Industry Forecast, 2022–2031
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms the utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high-quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
